Bachem, a leading partner in peptide and oligonucleotide manufacturing, today announced progress in its plans to expand capacity.

British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. The funds are set to be spread ...